Delivery Order SPE2DB20D2014-SPE2DB25FC93M
- Not listed
- The Defense Logistics Agency awarded a $4,992.08 delivery order to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 17, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $21,731.92 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location. This delivery order represents a competitive procurement action under the company's...
- The Defense Logistics Agency awarded a $3,252.20 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $26,828.48 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. As a non-set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.76 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL) with an ultimate completion date of May 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement needs. The delivery order is...
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order valued at $31,145.42 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Humulin R 500 Unit/mL KwikPen insulin pens (3mL). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $15,081.42 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $14,738.91. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with performance completion targeted for August 7, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for Humulin R 500 unit/mL KwikPen insulin pens (3mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and performance at the vendor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC93MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad portfolio of medications and medical supplies to support military and veteran healthcare systems. The parent IDC enables the company to provide specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for insulin represents the type of routine pharmaceutical procurement executed through the parent contract vehicle to support ongoing military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/5/25 |